FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204361199> ?p ?o ?g. }

• W3204361199 abstract "Abstract Background Prescription opioids account for more than 40% of opioid induced mortalities. With the trend towards increased opioid prescribing set to continue rising, opioid-based adverse drug reactions, (ADRs) and their associated human and financial cost present a major global public health concern. The review examined the relationship between CYP2D6 phenotypes and opioid metabolising. The aim was to establish whether screening for CYP2D6 phenotypes would improve existing opioid dosing strategies and reduce ADRs. Method A systematic review was conducted using the online Web of Science database. Selected key words and Boolean operator combinations were used to search the relevant literature. Identified studies were screened against pre-defined inclusion/exclusion criteria. Eligible studies were subject to full review and quality assessment. A narrative analysis was performed to synthesise data from the studies included in the final review. Results The review yielded five studies that met the eligibility criteria and were subject to full review. Four of the five studies reported significant effects of CYP2D6 phenotypes on opioid metabolising or opioid based ADRs. Three studies focused exclusively on pharmacokinetics, two studies focused exclusively on ADRs, and one study considered pharmacokinetics and ADRs. All pharmacokinetic studies reported a significant association between CYP2D6 phenotypes and opioid metabolising. Only one of the studies reported a significant association between CYP2D6 phenotypes and ADRs. Conclusion The majority of evidence considered in the review supports the role of CYP2D6 in the metabolising of opioids and opioid based ADRs. Consequently, CYP2D6 screening should be considered as a potential mechanism for improving existing opioid dosing strategies and reducing ADRs. There is a need for further higher quality primary data studies focusing specifically on CYP2D6 phenotyping in the context of dosage strategies and exploring impact in longitudinal designs. Future studies should also seek to develop cost effective CYP2D6 screening methods to help support the clinical significance of CYP2D6 phenotyping." @default.
• W3204361199 created "2021-10-11" @default.
• W3204361199 creator A5019410628 @default.
• W3204361199 creator A5058170483 @default.
• W3204361199 date "2021-10-07" @default.
• W3204361199 modified "2023-09-27" @default.
• W3204361199 title "The potential of CYP2D6 phenotyping to improve opioid dosing strategies" @default.
• W3204361199 cites W1570879128 @default.
• W3204361199 cites W1766115599 @default.
• W3204361199 cites W1966756094 @default.
• W3204361199 cites W1992746042 @default.
• W3204361199 cites W2000003743 @default.
• W3204361199 cites W2019683429 @default.
• W3204361199 cites W2048760198 @default.
• W3204361199 cites W2080432470 @default.
• W3204361199 cites W2084455052 @default.
• W3204361199 cites W2103369491 @default.
• W3204361199 cites W2106814405 @default.
• W3204361199 cites W2123295321 @default.
• W3204361199 cites W2143241001 @default.
• W3204361199 cites W2152506996 @default.
• W3204361199 cites W2156098321 @default.
• W3204361199 cites W2163614135 @default.
• W3204361199 cites W2166009764 @default.
• W3204361199 cites W2314579011 @default.
• W3204361199 cites W2528553606 @default.
• W3204361199 cites W2770319189 @default.
• W3204361199 cites W2809266094 @default.
• W3204361199 cites W2947568850 @default.
• W3204361199 cites W2987088650 @default.
• W3204361199 doi "https://doi.org/10.1101/2021.10.07.21264057" @default.
• W3204361199 hasPublicationYear "2021" @default.
• W3204361199 type Work @default.
• W3204361199 sameAs 3204361199 @default.
• W3204361199 citedByCount "0" @default.
• W3204361199 crossrefType "posted-content" @default.
• W3204361199 hasAuthorship W3204361199A5019410628 @default.
• W3204361199 hasAuthorship W3204361199A5058170483 @default.
• W3204361199 hasBestOaLocation W32043611991 @default.
• W3204361199 hasConcept C126322002 @default.
• W3204361199 hasConcept C170493617 @default.
• W3204361199 hasConcept C177713679 @default.
• W3204361199 hasConcept C2777288759 @default.
• W3204361199 hasConcept C2781063702 @default.
• W3204361199 hasConcept C3020000205 @default.
• W3204361199 hasConcept C33664856 @default.
• W3204361199 hasConcept C526171541 @default.
• W3204361199 hasConcept C62231903 @default.
• W3204361199 hasConcept C71924100 @default.
• W3204361199 hasConcept C98274493 @default.
• W3204361199 hasConceptScore W3204361199C126322002 @default.
• W3204361199 hasConceptScore W3204361199C170493617 @default.
• W3204361199 hasConceptScore W3204361199C177713679 @default.
• W3204361199 hasConceptScore W3204361199C2777288759 @default.
• W3204361199 hasConceptScore W3204361199C2781063702 @default.
• W3204361199 hasConceptScore W3204361199C3020000205 @default.
• W3204361199 hasConceptScore W3204361199C33664856 @default.
• W3204361199 hasConceptScore W3204361199C526171541 @default.
• W3204361199 hasConceptScore W3204361199C62231903 @default.
• W3204361199 hasConceptScore W3204361199C71924100 @default.
• W3204361199 hasConceptScore W3204361199C98274493 @default.
• W3204361199 hasLocation W32043611991 @default.
• W3204361199 hasOpenAccess W3204361199 @default.
• W3204361199 hasPrimaryLocation W32043611991 @default.
• W3204361199 hasRelatedWork W12104161 @default.
• W3204361199 hasRelatedWork W1233682 @default.
• W3204361199 hasRelatedWork W13516814 @default.
• W3204361199 hasRelatedWork W18157491 @default.
• W3204361199 hasRelatedWork W18589541 @default.
• W3204361199 hasRelatedWork W19234638 @default.
• W3204361199 hasRelatedWork W21917182 @default.
• W3204361199 hasRelatedWork W7537123 @default.
• W3204361199 hasRelatedWork W9635424 @default.
• W3204361199 hasRelatedWork W21706666 @default.
• W3204361199 isParatext "false" @default.
• W3204361199 isRetracted "false" @default.
• W3204361199 magId "3204361199" @default.
• W3204361199 workType "article" @default.